12-Month Results of the Standardised Combination Therapy for Diabetic Macular Oedema: Intravitreal Bevacizumab and Navigated Retinal Photocoagulation.
Authors: Barteselli, Giulio, Igor Kozak, Sharif El-Emam, Jay Chhablani, Marco A Cortes, and William R Freeman.
Presented: January 1, 2014
Type: Publications
Conclusion: “Standardized combination therapy using bevacizumab injections followed by navigated laser treatment for clinically significant diabetic macular oedema demonstrated significant visual gain and CRT reduction after bevacizumab treatment and stabilisation after navigated laser up to 12 months. The number of injections required in 12 months was lower than reported in previous combination studies.”
Related publications and webinars
- The treatment strategy and selected parameters presented in content listed here are solely the responsibility of the treating ophthalmologist, who is required to be familiar with the most recent literature/guidelines or recommendations, as well as with the usage of the Navilas Laser System according to the current Operator’s Manual.